Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Cardiovascular Diagnosis and Therapy|December 1, 2018
Antiplatelet therapy for peripheral artery diseaseRosetta Melfi, Elisabetta Ricottini
Cardiology in Review|July 23, 2014
Prognostic role of platelet reactivity in patients with acute coronary syndromesIlaria Cavallari, Annunziata Nusca, Elisabetta Ricottini, et al.
Progress in Cardiovascular Diseases|June 8, 2022
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when?Elisabetta Ricottini, Annunziata Nusca, Gian Paolo Ussia, et al.
Journal of Cardiovascular Pharmacology|January 16, 2016
Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: A Study-level Meta-analysis From 15 StudiesGiuseppe Patti, Elisabetta Ricottini, Leonardo De Luca, et al.
The American Journal of Cardiology|January 25, 2011
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)Giuseppe Patti, Vincenzo Pasceri, Vincenzo Vizzi, et al.
Diabetes/Metabolism Research and Reviews|July 21, 2018
Glycemic variability in the development of cardiovascular complications in diabetesAnnunziata Nusca, Dario Tuccinardi, Marzia Albano, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 14, 2016
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL studyFabio Mangiacapra, Iginio Colaiori, Elisabetta Ricottini, et al.
The American Journal of Cardiology|May 3, 2011
Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trialGiuseppe Patti, Elisabetta Ricottini, Annunziata Nusca, et al.
The American Journal of Cardiology|August 13, 2016
Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary InterventionEdoardo Bressi, Fabio Mangiacapra, Elisabetta Ricottini, et al.
The American Journal of Cardiology|March 25, 2018
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary AngioplastyElisabetta Ricottini, Fabio Mangiacapra, Annunziata Nusca, et al.
Pageof 6